Concepedia

Author

Ivan V. Pozhidaev

Tomsk National Research Medical CenterORCID

Also Known As

I V Pozhidaev, I. Pozhidaev, I. V. Pozhidaev, I.V. Pozhidaev, Ivan Pozhidaev, Ivan V Pozhidaev, Ivan V. Pozhidaev, Pozhidaev, Ivan, И.В Пожидаев, И.В. Пожидаев

78

Publications

408

Citations

14

H-Index

11

Concepts

All Affiliations

Tomsk National Research Medical CenterUniversity of GroningenSiberian State Medical UniversityNational Research Tomsk State UniversityRussian Academy of Sciences
IV

About

Ivan V. Pozhidaev is an author at Tomsk National Research Medical Center specializing in schizophrenia, medicine, and psychiatry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

62

2

Psychiatry

2

2

62

3

Social Sciences

1

1

34

4

Neurology

1

1

34

5

Neuroscience

1

1

34

Ivan V. Pozhidaev

×

17

Publications

333

Citations

14

H-Index

YearCitations

CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects

Svetlana А. Ivanova, Natalya M. Vyalova, Ivan V. Pozhidaev,

Bulletin of Experimental Biology and Medicine

2016

34

Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia

Svetlana А. Ivanova, Diana Z. Osmanova, Maxim B. Freidin,

The World Journal of Biological Psychiatry

2016

33

Prolactin gene polymorphism (− 1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics

Svetlana А. Ivanova, Diana Z. Osmanova, Anastasiia S. Boiko,

Schizophrenia Research

2016

28

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia

Diana Z. Osmanova, Maxim B. Freidin, Olga Fedorenko,

BMC Medical Genetics

2019

24

Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of<i>CHRM1</i>and<i>CHRM2</i>muscarinic receptors

Anastasiia S. Boiko, Svetlana А. Ivanova, Ivan V. Pozhidaev,

The World Journal of Biological Psychiatry

2019

21

Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression

Taichi Ochi, Natalya M. Vyalova, Innokentiy S. Losenkov,

Frontiers in Pharmacology

2019

21

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia

Lisanne M. Geers, Ivan V. Pozhidaev, Svetlana А. Ivanova,

British Journal of Clinical Pharmacology

2020

21

NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder

Аnastasia Levchenko, Natalya M. Vyalova, Timur Nurgaliev,

Frontiers in Genetics

2020

21

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia

Diana Z. Paderina, Anastasiia S. Boiko, Ivan V. Pozhidaev,

Journal of Personalized Medicine

2021

21

Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia

Svetlana А. Ivanova, Ivan V. Pozhidaev, Maxim B. Freidin,

Journal of Pharmacy & Pharmaceutical Sciences

2018

16

Page 1